Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel

被引:11
|
作者
Shah, Vishal P. [1 ,2 ]
Breeher, Laura E. [1 ,3 ]
Alleckson, Julie M. [3 ]
Rivers, David G. [3 ]
Wang, Zhen [2 ]
Stratton, Emily R. [1 ]
Farah, Wigdan [1 ]
Hainy, Caitlin M. [3 ]
Swift, Melanie D. [1 ,3 ]
机构
[1] Mayo Clin, Div Prevent Occupat & Aerosp Med, Rochester, MN 55905 USA
[2] Mayo Clin, Evidence Based Practice Res Program, Rochester, MN 55905 USA
[3] Mayo Clin, Occupat Hlth Serv, Rochester, MN USA
关键词
COVID-19; WORKERS;
D O I
10.1017/ice.2021.533
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To assess the rate and factors associated with healthcare personnel (HCP) testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) after an occupational exposure. Design: Retrospective cohort study. Setting: Academic medical center with sites in Minnesota, Wisconsin, Arizona, and Florida. Participants: HCP with a high or medium risk occupational exposure to a patient or other HCP with SARS-CoV-2. Methods: We reviewed the records of HCP with significant occupational exposures from March 20, 2020, through December 31, 2020. We then performed regression analysis to assess the impact of demographic and occupational variables to assess their impact on the likelihood of testing positive for SARS-CoV-2. Results: In total, 2,253 confirmed occupational exposures occurred during the study period. Employees were the source for 57.1% of exposures. Overall, 101 HCP (4.5%) tested positive in the postexposure period. Of these, 80 had employee sources of exposure and 21 had patient sources of exposure. The postexposure infection rate was 6.2% when employees were the source, compared to 2.2% with patient sources. In a multivariate analysis, occupational exposure from an employee source had a higher risk of testing positive compared to a patient source (odds ratio [OR], 3.22; 95% confidence interval [CI], 1.72-6.04). Sex, age, high-risk exposure, and HCP role were not associated with an increased risk of testing positive. Conclusions: The risk of acquiring coronavirus disease 2019 (COVID-19) following a significant occupational exposure has remained relatively low, even in the prevaccination era. Exposure to an infectious coworker carries a higher risk than exposure to a patient. Continued vigilance and precautions remain necessary in healthcare settings.
引用
收藏
页码:1785 / 1789
页数:5
相关论文
共 50 条
  • [21] Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise
    Nemunaitis, John
    Stanbery, Laura
    Senzer, Neil
    FUTURE VIROLOGY, 2020, 15 (06) : 381 - 395
  • [22] Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel
    Tande, Aaron J.
    Swift, Melanie D.
    Challener, Douglas W.
    Berbari, Elie F.
    Tommaso, Christopher P.
    Christopherson, Darrin R.
    Binnicker, Matthew J.
    Breeher, Laura E.
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E347 - E349
  • [23] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Febrile Infants Without Respiratory Distress
    Paret, Michal
    Lighter, Jennifer
    Madan, Rebecca Pellett
    Raabe, Vanessa N.
    Shust, Gail F.
    Ratner, Adam J.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (16) : 2243 - 2245
  • [24] Risk and protective factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers: A test-negative case-control study in Quebec, Canada
    Carazo, Sara
    Villeneuve, Jasmin
    Laliberte, Denis
    Longtin, Yves
    Talbot, Denis
    Martin, Richard
    Denis, Geoffroy
    Ducharme, Francine
    Paquet-Bolduc, Bianka
    Anctil, Genevieve
    Hegg-Deloye, Sandrine
    De Serres, Gaston
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2023, 44 (07) : 1121 - 1130
  • [25] Transmission risk of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) to healthcare personnel following unanticipated exposure to aerosol-generating procedures: Experience from epidemiologic investigations at an academic medical center
    Fawcett, Sharon E.
    Madhusudhan, Meghan S.
    Gaddam, Emily N.
    Almario, Matthew J.
    Masih, Shawna R.
    Klute-Evans, Dee Dee
    Johnson, Julie C.
    Stroud, Clarise D.
    Dolan-Caren, Judy A.
    Ben-Aderet, Michael A.
    Luria, Jeffery
    Morgan, Margie A.
    Vail, Eric
    Grein, Jonathan D.
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2023, 44 (02) : 325 - 327
  • [26] Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) Among Adults
    Parker, Anna M.
    Jackson, Nicole
    Awasthi, Shevya
    Kim, Hanna
    Alwan, Tess
    Wyllie, Anne L.
    Baldwin, Alisha B.
    Brennick, Nicole B.
    Moehle, Erica A.
    Giannikopoulos, Petros
    Kogut, Katherine
    Holland, Nina
    Mora-Wyrobek, Ana
    Eskenazi, Brenda
    Riley, Lee W.
    Lewnard, Joseph A.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (07) : 1209 - 1217
  • [27] Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2)
    Maveddat, Ashley
    Mallah, Haneen
    Rao, Sanjana
    Ali, Kiran
    Sherali, Samir
    Nugent, Kenneth
    INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2020, 11 (04) : 157 - 178
  • [29] JMM Profile: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Inglis, Timothy J. J.
    Mathee, Kalai
    JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 70 (03)
  • [30] Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel
    Swift, Melanie D.
    Breeher, Laura E.
    Tande, Aaron J.
    Tommaso, Christopher P.
    Hainy, Caitlin M.
    Chu, Haitao
    Murad, M. Hassan
    Berbari, Elie F.
    Virk, Abinash
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) : E1376 - E1379